IVD Department Quantitative NT-proBNP Testing - Vietnam Registration 2403391ĐKLH/BYT-HTTB
Access comprehensive regulatory information for IVD Department Quantitative NT-proBNP Testing in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2403391ĐKLH/BYT-HTTB. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Siemens Healthineers, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403391ĐKLH/BYT-HTTB
000.00.04.G18-231213-0003
Theo theo phụ lục
Theo phụ lục
Technical Details
Roche CARDIAC POC NT-proBNP: Roche CARDIACPOCNT‑proBNP is an in vitro diagnostic test designed to determine the concentration of NT-proBNP in heparinized venous blood, to be used with the cobash232 instrument. The Roche CARDIACPOCNT‑proBNP test aims to support the diagnosis of patients suspected of having heart failure, to monitor patients with compensated left ventricular dysfunction, and to stratify the risk of patients with acute coronary syndrome. This test can help assess the risk of cardiovascular disease in patients with type 2 diabetes. It is also indicated to support the determination of patients with type 2 diabetes at risk of cardiovascular disease, where the medical history of cardiovascular disease is unclear, in order to optimize the treatment strategy for cardiovascular protection. This test can be used to identify individuals at high risk of atrial fibrillation. The test is intended for use near the patient. It is not intended for self-testing. Roche CARDIAC POC NT-proBNP Control: RocheCARDIACPOCNT‑proBNP Control is used to control the quality of the Roche CARDIACPOC NT-proBNP test on the cobash232 instrument. It is a control sample used for the near-patient testing. It is not intended for self-testing.
Dates and Status
Nov 06, 2024